Infectious diseases caused by pathogens such as bacteria, viruses, fungi and parasites. Infectious diseases spread from person to person whether directly or indirectly by insect bites or other vectors such as food, soil, water and air. Diagnosis is the detection of disease-causing agents by observing the symptoms of the infected person. It plays a crucial role in the decision-making process surrounding the accurate management of infectious and other diseases.
The global market for infectious disease diagnostics is projected to be worth US$1,131.4 million by 2020 and is anticipated to hit US$1,841.2 million by the end of 2027.
Global Infectious Disease Diagnosis Market: Prospects
The launch of cost-effective and reliable test kits is expected to generate lucrative growth opportunities for market players. There are currently very few reliable diagnostic test kits available for infectious diseases. The lack of availability of effective diagnostic tools and the reasonable value of existing test kits has sparked the need for expense test kits with high specificity and sensitivity.
In addition, R&D in diagnostic kits is also anticipated to produce to market growth. For example, in September 2019, researchers at the University of Helsinki, Finland, reported that antibody response to Puumala orthohantavirus can be measured at a sensitive and specific with the unorthodox point-of-care assay LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection using urine as a sample matrix.
To Further Information about Infectious Disease Diagnosis Market: https://www.globenewswire.com/news-release/2020/05/22/2037671/0/en/Infectious-Disease-Diagnostics-Market-to-reach-US-1-841-2-Million-globally-by-2027-Coherent-Market-Insights.html